During the past decade, Loma Linda University conducted 100 clinical trials. In the 10-year time frame, 100 clinical trials started and 38 clinical trials were completed, i.e. on average, 38% percent of trials that started reached the finish line to date. In the past 5 years, 50 clinical trials started and 20 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Loma Linda University" #1 sponsor was "Loma Linda University" with 74 trials, followed by "Colgate Palmolive" with 3 trials sponsored, "Genentech, Inc." with 3 trials sponsored, "Novartis Pharmaceuticals" with 3 trials sponsored and "Pacira Pharmaceuticals, Inc" with 3 trials sponsored. Other sponsors include 63 different institutions and companies that sponsored additional 63 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Loma Linda University" #1 collaborator was "Loma Linda University" with 6 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator, "PPD" with 3 trials as a collaborator and "University of Pittsburgh" with 3 trials as a collaborator. Other collaborators include 89 different institutions and companies that were collaborators in the rest 90 trials.

According to Clinical.Site data, the most researched conditions in "Loma Linda University" are "Cervical Dystonia" (4 trials), "Pain" (4 trials), "Amputation" (3 trials), "Geographic Atrophy" (3 trials) and "Autism Spectrum Disorder" (2 trials). Many other conditions were trialed in "Loma Linda University" in a lesser frequency.

Most popular intervention types in "Loma Linda University" are "Drug" (56 trials), "Other" (46 trials), "Device" (21 trials), "Behavioral" (12 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Sham" (3 trials), "ABP-450" (2 trials), "Bupivacaine" (2 trials) and "Lampalizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Loma Linda University" are 143 trials for "All" genders, 6 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Loma Linda University". 1 are not yet recruiting, 25 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 88 completed trials in Loma Linda University, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Loma Linda University, 6 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 72 trials that are defined as “Not Applicable".

Loma Linda University has several departments that took part in Clinical trials: "Loma Linda University School of Dentistry" - 6 trials, "Loma Linda University, Department of Nutrition" - 2 trials, "Center for Dental Research Loma Linda University School" - 2 trials